400 related articles for article (PubMed ID: 9693110)
1. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
[TBL] [Abstract][Full Text] [Related]
3. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.
Gribble AD; Ife RJ; Shaw A; McNair D; Novelli CE; Bakewell S; Shah VP; Dolle RE; Groot PH; Pearce N; Yates J; Tew D; Boyd H; Ashman S; Eggleston DS; Haltiwanger RC; Okafo G
J Med Chem; 1998 Sep; 41(19):3582-95. PubMed ID: 9733484
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
[TBL] [Abstract][Full Text] [Related]
6. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
al-Shurbaji A; Skorve J; Berge RK; Rudling M; Björkhem I; Berglund L
Arterioscler Thromb; 1993 Nov; 13(11):1580-6. PubMed ID: 8218098
[TBL] [Abstract][Full Text] [Related]
7. Hypolipidemic activity of the surfactants aminimides, and their effects on lipid metabolism of rodents.
Hall IH; Kabara JJ; Matthews TG
Lipids; 1985 Oct; 20(10):685-92. PubMed ID: 2865666
[TBL] [Abstract][Full Text] [Related]
8. ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.
Gribble AD; Dolle RE; Shaw A; McNair D; Novelli R; Novelli CE; Slingsby BP; Shah VP; Tew D; Saxty BA; Allen M; Groot PH; Pearce N; Yates J
J Med Chem; 1996 Aug; 39(18):3569-84. PubMed ID: 8784456
[TBL] [Abstract][Full Text] [Related]
9. Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia.
Lemus HN; Mendivil CO
J Clin Lipidol; 2015; 9(3):384-9. PubMed ID: 26073398
[TBL] [Abstract][Full Text] [Related]
10. Mendelian Randomization Study of
Ference BA; Ray KK; Catapano AL; Ference TB; Burgess S; Neff DR; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Kastelein JJP; Nicholls SJ
N Engl J Med; 2019 Mar; 380(11):1033-1042. PubMed ID: 30865797
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats.
Skorve J; al-Shurbaji A; Asiedu D; Björkhem I; Berglund L; Berge RK
J Lipid Res; 1993 Jul; 34(7):1177-85. PubMed ID: 8371065
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice.
Wang Q; Li S; Jiang L; Zhou Y; Li Z; Shao M; Li W; Liu Y
J Lipid Res; 2010 Sep; 51(9):2516-26. PubMed ID: 20488800
[TBL] [Abstract][Full Text] [Related]
13. ATP citrate lyase inhibition can suppress tumor cell growth.
Hatzivassiliou G; Zhao F; Bauer DE; Andreadis C; Shaw AN; Dhanak D; Hingorani SR; Tuveson DA; Thompson CB
Cancer Cell; 2005 Oct; 8(4):311-21. PubMed ID: 16226706
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
15. Hypolipidemic activity of benzohydroxamic acids and dibenzohydroxamic acids in rodents.
Izydore RA; Debnath ML; Woodard T; Wong OT; Hall IH
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):307-21. PubMed ID: 2151200
[TBL] [Abstract][Full Text] [Related]
16. Effect of dietary cholesterol on hepatic lipogenesis and plasma insulin and free fatty acid levels in rats.
Tsai AC; Romos DR; Leveille GA
J Nutr; 1975 Jul; 105(7):939-45. PubMed ID: 1138036
[TBL] [Abstract][Full Text] [Related]
17. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.
Koerner SK; Hanai JI; Bai S; Jernigan FE; Oki M; Komaba C; Shuto E; Sukhatme VP; Sun L
Eur J Med Chem; 2017 Jan; 126():920-928. PubMed ID: 27997879
[TBL] [Abstract][Full Text] [Related]
19. Bempedoic acid: effect of ATP-citrate lyase inhibition on low-density lipoprotein cholesterol and other lipids.
Paton DM
Drugs Today (Barc); 2020 Sep; 56(9):573-582. PubMed ID: 33025951
[TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
Pinkosky SL; Filippov S; Srivastava RA; Hanselman JC; Bradshaw CD; Hurley TR; Cramer CT; Spahr MA; Brant AF; Houghton JL; Baker C; Naples M; Adeli K; Newton RS
J Lipid Res; 2013 Jan; 54(1):134-51. PubMed ID: 23118444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
